Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Lausanne-based Adaptyv raises €34.35 million Series A led by Highland Europe to expand its automated lab for AI-driven protein design.
PRIVATEAug 27, 2026•about 3 hours ago
Amount Raised
€34.4 Million
Round Type
Series A
LausanneBiotechnologyArtificial Intelligence
Investors
Y CombinatorBy FoundersAce VenturesHighland Europe
Description
Adaptyv Bio has successfully raised €34.35 million in a Series A funding round to enhance its lab capacity for automated wet lab processes. The round was primarily led by Highland Europe, with significant contributions from existing investors Ace Ventures, ByFounders, and Y Combinator. This funding will allow Adaptyv to tackle more complex biology challenges and support its growth. The startup has seen remarkable expansion, tripling its team and greatly increasing revenue since its Seed round in late 2024.
Company Information
Company
Adaptyv Bio
Location
Lausanne, Vaud, Switzerland
About
Adaptyv Bio is a Lausanne-based BioTech startup focused on building an automated wet lab for AI-driven protein design. The company aims to bridge the gap in biochemistry by significantly increasing the throughput of experiments to handle thousands of designs. It incorporates in-house DNA synthesis and offers a digital platform for customers to submit their designs for testing. With notable collaborations and a growing client base, Adaptyv is set to advance the field of protein discovery and design.
Don't miss Adaptyv Bio's next move
Get an email the moment Adaptyv Bio raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Adaptyv Bio's next move
LausanneBiotechnologyArtificial Intelligence